# Auddia Inc.: financial statements, quarterly

AUUD · Nasdaq · CIK 1554818 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/auud.md) · [Financials](/companies/auud/financials.md) · [Filings](/companies/auud/filings.md) · [Insiders](/companies/auud/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/auud/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0001683168-24-007746.md) | [0.0 d](/filings/0001683168-25-001357.md) | [0.0](/filings/0001683168-25-003292.md) | [0.0](/filings/0001683168-25-005802.md) | [0.0](/filings/0001683168-25-008031.md) | [0.0 d](/filings/0001683168-26-001587.md) | [0.0](/filings/0001683168-26-004032.md) | [0.0](/filings/0001683168-26-006478.md) | [0.0](/filings/0001683168-25-008031.md) | [0.0 d](/filings/0001683168-26-001587.md) | [0.0](/filings/0001683168-26-004032.md) | [7.6](/filings/0001683168-26-006478.md) |
| Research and development | $k | [227](/filings/0001683168-24-007746.md) | [163 d](/filings/0001683168-25-001357.md) | [166](/filings/0001683168-25-003292.md) | [160](/filings/0001683168-25-005802.md) | [233](/filings/0001683168-25-008031.md) | [462 d](/filings/0001683168-26-001587.md) | [397](/filings/0001683168-26-004032.md) | [236](/filings/0001683168-26-006478.md) | [318](/filings/0001683168-25-008031.md) | [195 d](/filings/0001683168-26-001587.md) | [285](/filings/0001683168-26-004032.md) | [406](/filings/0001683168-26-006478.md) |
| Operating income | $k | [(1,830)](/filings/0001683168-24-007746.md) | [(2,015) d](/filings/0001683168-25-001357.md) | [(2,055)](/filings/0001683168-25-003292.md) | [(1,654)](/filings/0001683168-25-005802.md) | [(1,948)](/filings/0001683168-25-008031.md) | [(2,260) d](/filings/0001683168-26-001587.md) | [(1,751)](/filings/0001683168-26-004032.md) | [(1,567)](/filings/0001683168-26-006478.md) | [(2,380)](/filings/0001683168-25-008031.md) | [(1,999) d](/filings/0001683168-26-001587.md) | [(2,288)](/filings/0001683168-26-004032.md) | [(3,024)](/filings/0001683168-26-006478.md) |
| Interest expense | $k | [287](/filings/0001683168-24-007746.md) | [198 d](/filings/0001683168-25-001357.md) | [153](/filings/0001683168-25-003292.md) | [16.6](/filings/0001683168-25-005802.md) | [1.6](/filings/0001683168-25-008031.md) | [1.6 d](/filings/0001683168-26-001587.md) | [1.6](/filings/0001683168-26-004032.md) | [1.4](/filings/0001683168-26-006478.md) | [1.2](/filings/0001683168-25-008031.md) | [(8.6) d](/filings/0001683168-26-001587.md) | [(6.9)](/filings/0001683168-26-004032.md) | [(48.7)](/filings/0001683168-26-006478.md) |
| Income tax | $k | [0.0](/filings/0001683168-24-007746.md) | [0.0 d](/filings/0001683168-25-001357.md) | [0.0](/filings/0001683168-25-003292.md) | [0.0](/filings/0001683168-25-005802.md) | [0.0](/filings/0001683168-25-008031.md) | [0.0 d](/filings/0001683168-26-001587.md) | [0.0](/filings/0001683168-26-004032.md) | [0.0](/filings/0001683168-26-006478.md) | [0.0](/filings/0001683168-25-008031.md) | [0.0 d](/filings/0001683168-26-001587.md) | [0.0](/filings/0001683168-26-004032.md) | [0.0](/filings/0001683168-26-006478.md) |
| Net income | $k | [(2,116)](/filings/0001683168-24-007746.md) | [(2,213) d](/filings/0001683168-25-001357.md) | [(2,207)](/filings/0001683168-25-008031.md) | [(2,303)](/filings/0001683168-25-008031.md) | [(1,949)](/filings/0001683168-25-008031.md) | [(2,262) d](/filings/0001683168-26-001587.md) | [(1,753)](/filings/0001683168-26-006478.md) | [(1,569)](/filings/0001683168-26-006478.md) | [(2,381)](/filings/0001683168-25-008031.md) | [(1,991) d](/filings/0001683168-26-001587.md) | [(2,282)](/filings/0001683168-26-006478.md) | [(2,975)](/filings/0001683168-26-006478.md) |
| Diluted EPS | $ per share | [(2.65)](/filings/0001683168-24-007746.md) | not reported | [(33.69)](/filings/0001683168-25-003292.md) | [(14.62)](/filings/0001683168-25-005802.md) | [(8.45)](/filings/0001683168-25-008031.md) | not reported | [(29.69)](/filings/0001683168-26-004032.md) | [(22.69)](/filings/0001683168-26-006478.md) | [(1.59)](/filings/0001683168-25-008031.md) | not reported | [(5.09)](/filings/0001683168-26-004032.md) | [(0.71)](/filings/0001683168-26-006478.md) |
| Basic EPS | $ per share | [(2.65)](/filings/0001683168-24-007746.md) | not reported | [(33.69)](/filings/0001683168-25-003292.md) | [(14.62)](/filings/0001683168-25-005802.md) | [(8.45)](/filings/0001683168-25-008031.md) | not reported | [(29.69)](/filings/0001683168-26-004032.md) | [(22.69)](/filings/0001683168-26-006478.md) | [(1.59)](/filings/0001683168-25-008031.md) | not reported | [(5.09)](/filings/0001683168-26-004032.md) | [(0.71)](/filings/0001683168-26-006478.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.2](/filings/0001683168-23-008138.md) | [0.8](/filings/0001683168-25-001357.md) | [2.7](/filings/0001683168-24-003403.md) | [1.9](/filings/0001683168-24-005345.md) | [3.8](/filings/0001683168-24-007746.md) | [2.7](/filings/0001683168-26-001587.md) | [1.7](/filings/0001683168-25-003292.md) | [1.1](/filings/0001683168-25-005802.md) | [2.7](/filings/0001683168-25-008031.md) | [3.2](/filings/0001683168-26-001587.md) | [1.4](/filings/0001683168-26-004032.md) | [9.6](/filings/0001683168-26-006478.md) |
| Current assets | $m | [2.3](/filings/0001683168-23-008138.md) | [0.9](/filings/0001683168-25-001357.md) | [2.8](/filings/0001683168-24-003403.md) | [2.0](/filings/0001683168-24-005345.md) | [3.8](/filings/0001683168-24-007746.md) | [2.8](/filings/0001683168-26-001587.md) | [1.8](/filings/0001683168-25-003292.md) | [1.2](/filings/0001683168-25-005802.md) | [2.8](/filings/0001683168-25-008031.md) | [3.3](/filings/0001683168-26-006478.md) | [1.5](/filings/0001683168-26-004032.md) | [9.7](/filings/0001683168-26-006478.md) |
| Total assets | $m | [6.0](/filings/0001683168-23-008138.md) | [4.4](/filings/0001683168-25-001357.md) | [6.2](/filings/0001683168-24-003403.md) | [5.1](/filings/0001683168-24-005345.md) | [6.7](/filings/0001683168-24-007746.md) | [5.3](/filings/0001683168-26-001587.md) | [4.1](/filings/0001683168-25-003292.md) | [3.4](/filings/0001683168-25-005802.md) | [4.9](/filings/0001683168-25-008031.md) | [5.2](/filings/0001683168-26-006478.md) | [3.5](/filings/0001683168-26-004032.md) | [11.5](/filings/0001683168-26-006478.md) |
| Current liabilities | $m | [3.6](/filings/0001683168-23-008138.md) | [4.0](/filings/0001683168-25-001357.md) | [4.2](/filings/0001683168-24-003403.md) | [0.4](/filings/0001683168-24-005345.md) | [0.5](/filings/0001683168-24-007746.md) | [0.6](/filings/0001683168-26-001587.md) | [0.4](/filings/0001683168-25-003292.md) | [0.5](/filings/0001683168-25-005802.md) | [0.6](/filings/0001683168-25-008031.md) | [1.0](/filings/0001683168-26-006478.md) | [0.7](/filings/0001683168-26-004032.md) | [0.9](/filings/0001683168-26-006478.md) |
| Total liabilities | $m | [3.6](/filings/0001683168-23-008138.md) | [4.0](/filings/0001683168-25-001357.md) | [4.3](/filings/0001683168-24-003403.md) | [0.4](/filings/0001683168-24-005345.md) | [0.6](/filings/0001683168-24-007746.md) | [0.6](/filings/0001683168-26-001587.md) | [0.4](/filings/0001683168-25-003292.md) | [0.6](/filings/0001683168-25-005802.md) | [0.7](/filings/0001683168-25-008031.md) | [1.0](/filings/0001683168-26-006478.md) | [0.7](/filings/0001683168-26-004032.md) | [0.9](/filings/0001683168-26-006478.md) |
| Shareholders' equity | $m | [2.4](/filings/0001683168-24-007746.md) | [0.4](/filings/0001683168-26-001587.md) | [1.9](/filings/0001683168-25-008031.md) | [4.7](/filings/0001683168-25-008031.md) | [6.1](/filings/0001683168-25-008031.md) | [4.7](/filings/0001683168-26-006478.md) | [3.6](/filings/0001683168-26-006478.md) | [2.9](/filings/0001683168-26-006478.md) | [4.2](/filings/0001683168-25-008031.md) | [4.2](/filings/0001683168-26-006478.md) | [2.8](/filings/0001683168-26-006478.md) | [10.7](/filings/0001683168-26-006478.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,190) d](/filings/0001683168-24-007746.md) | [(1,099) d](/filings/0001683168-25-001357.md) | [(1,405)](/filings/0001683168-25-003292.md) | [(1,229) d](/filings/0001683168-25-005802.md) | [(1,170) d](/filings/0001683168-25-008031.md) | [(1,290) d](/filings/0001683168-26-001587.md) | [(1,443)](/filings/0001683168-26-004032.md) | [(1,065) d](/filings/0001683168-26-006478.md) | [(1,827) d](/filings/0001683168-25-008031.md) | [(1,298) d](/filings/0001683168-26-001587.md) | [(2,275)](/filings/0001683168-26-004032.md) | [(2,508) d](/filings/0001683168-26-006478.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001683168-24-007746.md) | [2.4 d](/filings/0001683168-25-001357.md) | not reported | not reported | [3.7 d](/filings/0001683168-24-007746.md) | [(0.0) d](/filings/0001683168-25-001357.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.5](/filings/0001683168-23-008138.md) | [0.5](/filings/0001683168-24-003403.md) | [0.6](/filings/0001683168-24-005345.md) | [0.8](/filings/0001683168-24-007746.md) | [0.1](/filings/0001683168-25-003292.md) | [0.2](/filings/0001683168-25-005802.md) | [0.2](/filings/0001683168-25-008031.md) | [0.1](/filings/0001683168-26-004032.md) | [0.1](/filings/0001683168-26-006478.md) | [1.5](/filings/0001683168-25-008031.md) | [0.4](/filings/0001683168-26-004032.md) | [4.2](/filings/0001683168-26-006478.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,803,050 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001683168-26-006478.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.